Cover Image
市場調查報告書

學名藥製造工廠計劃:產業趨勢、製造工程、機器、原料、原價收益

Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

出版商 IMARC Services Pvt. Ltd. 商品編碼 344762
出版日期 內容資訊 英文 84 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
學名藥製造工廠計劃:產業趨勢、製造工程、機器、原料、原價收益 Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022
出版日期: 2017年04月03日 內容資訊: 英文 84 Pages
簡介

學名藥 (非專利處方藥) ,是接續於新藥 (首發醫藥品) 的醫藥品,在劑量、使用目的、有效性中有兼容性。通常學名藥在新藥的專利失效後銷售。

本報告提供學名藥製造工廠計劃調查分析、建設工廠的技術與商業性藍圖、業績、製造工程必要條件、計劃的經費、資金援助、經濟性等相關驗證等系統性資訊。

第1章 調查手法

第2章 摘要整理

第3章 簡介

第4章 學名藥產業分析

  • 學名藥的分類
  • 市場趨勢
  • 學名藥的價值鏈分析
  • 學名藥製造商主要成功因素
  • 學名藥產業的法規

第5章 學名藥的製造工程

  • 詳細的流程
  • 學名藥製造工廠:原料必要條件

第6章 計劃詳細內容、必要條件、經費

  • 土地、場所、場地平整
  • 工廠設計
  • 工廠機器
  • 原料
  • 包裝
  • 公共事業
  • 人力資源
  • 其他資本投資

第7章 學名藥製造工廠:計劃的經濟性

  • 計劃的資本成本
  • 技術、經濟參數
  • 產品價格
  • 所得預測
  • 支出預測
  • 財務分析

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: SRP00116IQ

A generic drug is a pharmaceutical product that is generally intended to be interchangeable with an innovator or a branded drug. Generics are manufactured without a licence from the innovator company and are identical or bio-equivalent to an innovator drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. Generic drugs are launched and marketed after the expiry date of the patent or other exclusive rights. Although generic drugs are chemically identical to their branded counterparts, they are typically sold at substantial discounts from the branded price. Unlike branded drug manufacturers who spend millions of dollars on R&D and marketing, generic drug manufacturers do not require such investments. Since the drug's formula is known, the clinical trials are complete; the generic drug manufacturer's only requirement is to demonstrate to the regulators that its version is as good and effective as the innovator or branded drug.

According to the IMARC Group, the global generic drugs market was valued at around US$ 228.8 Billion in 2016, growing at a CAGR of around 9% during 2010-2016. The biggest catalyst for growth is an increasing global pharmaceutical spending trend towards generics. Continuously increasing healthcare expenditures have pushed governments and third-party payers to seek ways to control their healthcare expenditures. This is catalyzing an increasing demand for generics versus their branded counterparts. Another major driver of this industry is the continued patent cliff that is providing growing pipelines opportunities for generic firms. Similarly, a growth in the overall global population and aging demographics is also proving to be beneficial for the overall healthcare sector including generic drug manufacturers. Healthcare reforms in the US and other developed markets coupled with strong growth in emerging market are some other important drivers for the generic drugs market.

IMARC's latest study "Generic Drugs Market: Global Industry Trends, Manufacturing Process, Share, Size, Growth, Opportunity and Forecast 2017-2022" provides a comprehensive roadmap for stakeholders who are planning to setup and run a generic drugs manufacturing plant. The study covers all the requisite aspects of the generic drugs market. This ranges from macro overview of the market, industry performance, processing and manufacturing requirements, project cost, project funding, project economics, expected returns on investment, profit margins, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who are planning to foray into the generic drugs market in any manner.

Key Questions Answered in This Report:

  • How has the generic drug market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global generic drug industry?
  • What are the various stages in the value chain of the generic drug industry?
  • What are the key driving factors and challenges in the generic drug industry?
  • What is the structure of the generic drug industry and who are the key players?
  • What is the degree of competition in the generic drug industry?
  • What are the profit margins in the generic drug industry?
  • What are the key requirements for setting up generic drug manufacturing plant?
  • How are generic drug manufactured?
  • What are the various unit operations involved in generic drug plant?
  • What is the total size of land required for setting up generic drug plant?
  • What are the machinery requirements for setting up generic drug plant?
  • What are the raw material requirements for setting up generic drug plant?
  • What are the packaging requirements for generic drug?
  • What are the transportation requirements for generic drug?
  • What are the utility requirements for setting up generic drug plant?
  • What are the manpower requirements for setting up generic drug plant?
  • What are the infrastructure costs for setting up generic drug plant?
  • What are the capital costs for setting up generic drug plant?
  • What are the operating costs for setting up generic drug plant?
  • What will be the income and expenditures for generic drug plant?
  • What is the time required to break-even?

Table of Contents

1 Preface

2 Research Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Generic Drug Industry

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Market Breakup by Region
  • 5.4 Market Forecast
  • 5.5 SWOT Analysis
    • 5.5.1 Strengths
    • 5.5.2 Weaknesses
    • 5.5.3 Opportunities
    • 5.5.4 Threats
  • 5.6 Value Chain Analysis
  • 5.7 Porter's Five Forces Analysis
    • 5.7.1 Overview
    • 5.7.2 Bargaining Power of Buyers
    • 5.7.3 Bargaining Power of Suppliers
    • 5.7.4 Degree of Competition
    • 5.7.5 Threat of New Entrants
    • 5.7.6 Threat of Substitutes
  • 5.8 Regulations in Generic Industry
  • 5.9 Key Market Drivers and Success Factors

6 Performance of Key Regions

  • 6.1 USA
  • 6.2 China
  • 6.3 Brazil
  • 6.4 Germany
  • 6.5 France

7 Competitive Landscape

  • 7.1 Competitive Structure
  • 7.2 Market Breakup by Key Players
  • 7.3 Key Player Profiles
    • 7.3.1 Teva Pharmaceuticals
    • 7.3.2 Novartis - Sandoz
    • 7.3.3 Mylan
    • 7.3.4 Freseunis
    • 7.3.5 Hospira

8 Generic Drug Manufacturing Process

  • 8.1 Product Overview
  • 8.2 Detailed Process Flow (Tablets)
  • 8.3 Detailed Process Flow (Injectable)
  • 8.4 Various Types of Unit Operations Involved
  • 8.5 Mass Balance and Raw Material Requirements

9 Project Details, Requirements and Costs Involved

  • 9.1 Land Requirements and Expenditures
  • 9.2 Construction Requirements and Expenditures
  • 9.3 Plant Machinery
  • 9.4 Machinery Pictures
  • 9.5 Raw Material Requirements and Expenditures
  • 9.6 Packaging Requirements and Expenditures
  • 9.7 Transportation Requirements and Expenditures
  • 9.8 Utility Requirements and Expenditures
  • 9.9 Manpower Requirements and Expenditures
  • 9.10 Other Capital Investments

10 Loans and Financial Assistance

11 Project Economics

  • 11.1 Capital Cost of the Project
  • 11.2 Techno-Economic Parameters
  • 11.3 Product Pricing and Margins Across Various Levels of the Supply Chain
  • 11.4 Taxation and Depreciation
  • 11.5 Income Projections
  • 11.6 Expenditure Projections
  • 11.7 Financial Analysis
  • 11.8 Profit Analysis

List of Figures

  • Figure 1: Global: Generic Drug Industry Overview
  • Figure 2: Global: Generic Drug Market: Sales Value Trends (in Billion US$), 2010 - 2016
  • Figure 3: Global: Generic Drug Market Forecast: Sales Value Trends (in Billion US$), 2017 - 2022
  • Figure 4: Global: Generic Drug Market: Breakup by Region (in %), 2016
  • Figure 5: Global: Generic Drug Industry: SWOT Analysis
  • Figure 6: Global: Generic Drug Industry: Value Chain Analysis
  • Figure 7: Global: Generic Drug Industry: Porter's Five Forces Analysis
  • Figure 8: USA: Generic Drug Market (in Million US$), 2010, 2016 & 2022
  • Figure 9: China: Generic Drug Market (in Million US$), 2010, 2016 & 2022
  • Figure 10: Brazil: Generic Drug Market (in Million US$), 2010, 2016 & 2022
  • Figure 11: Germany: Generic Drug Market (in Million US$), 2010, 2016 & 2022
  • Figure 12: France: Generic Drug Market (in Million US$), 2010, 2016 and 2022
  • Figure 13: Generic Drug Tiles Industry: Profit Margins at Various Levels of the Supply Chain
  • Figure 14: Generic Drug Manufacturing: Production Cost Breakup (in %)
  • Figure 15: Generic Drug Manufacturing Plant: Detailed Process Flow
  • Figure 16: Generic Drug Manufacturing Process: Conversion Rate of Feedstocks
  • Figure 17: Generic Drug Manufacturing Plant: Proposed Plant Layout
  • Figure 18: Generic Drug Manufacturing Plant: Breakup of Capital Costs (in %)

List of Tables

  • Table 1: Global: Generic Drug Market: Key Industry Highlights, 2016 and 2022
  • Table 2: Global: Generic Drug Market Forecast: Breakup by Region, 2017-2022
  • Table 3: Generic Drug Manufacturing Plant: Costs Related to Land and Site Development (in US$)
  • Table 4: Generic Drug Manufacturing Plant: Costs Related to Civil Works (in US$)
  • Table 5: Generic Drug Manufacturing Plant: Costs Related to Machinery Unit (in US$)
  • Table 6: Generic Drug Manufacturing Plant: Raw Material Requirements
  • Table 7: Generic Drug Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
  • Table 8: Generic Drug Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
  • Table 9: Details of Financial Assistance Offered by Financial Institutions
  • Table 10: Generic Drug Manufacturing Plant: Capital Costs (in US$)
  • Table 11: Generic Drug Manufacturing Plant: Techno-Economic Parameters
  • Table 12: Generic Drug Manufacturing Plant: Taxation and Depreciation (in US$)
  • Table 13: Generic Drug Manufacturing Plant: Income Projections (in US$)
  • Table 14: Generic Drug Manufacturing Plant: Expenditure Projections (in US$)
  • Table 15: Generic Drug Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability
  • Table 16: Generic Drug Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability
  • Table 17: Generic Drug Manufacturing Plant: Profit and Loss Account
Back to Top